Journal of Neuro-Oncology

, Volume 91, Issue 2, pp 165–174 | Cite as

STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells

  • Guang-hui Li
  • Hong Wei
  • Zheng-tang Chen
  • Sheng-qing Lv
  • Chang-lin Yin
  • Dong-lin Wang
Laboratory Investigation - Human/animal tissue
First Online:
Received:
Accepted:

Abstract

Glioblastoma multiforme (GBM), the most common type of central nervous system tumor in humans, is highly proliferative and resistant to apoptosis associated with genetic mutations that deregulate cell cycle. Signal transduction and activation of transcription 3 (Stat3) is a key signal transduction protein that mediated signaling by cytokines and contributed to oncogenesis. It is constitutively activated in numerous cancers including glioblastoma. To determine the effect on proliferation and differentiation of glioblastoma U251 cells after inhibiting STAT3 expression by RNAi, STAT3 gene was silenced with lentivirus vector in U251 cells. We demonstrate that a lentivirus-based shRNA vector had highly infecting efficiency to U251 cells and lentivirus vector-mediated RNAi significantly suppressed Stat3 expression and activation in U251 cells. Knockdown of STAT3 expression by RNAi suppressed the growth and induced apoptosis of U251 cells by down-regulating expression of Bcl-2. It was found that the cell proportion of G0/G1 phase significantly increased after silencing Stat3 by down-regulating expression of cyclin D1. Knockdown of Stat3 also induces morphological changes of U251 cell. It increases significantly expression of myelin basic protein (MBP) in U251 cells. This study demonstrates that STAT3 silencing with lentivirus effectively inhibits STAT3 gene expression and activation. Stat3 is associated with the survival, growth and differentiation of U251 cells. Lentivirus vector-mediated RNAi may be serve as a novel therapeutic strategy for treatment of GBM with expression constitutively and activation of STAT3 gene.

Keywords

Glioblastoma RNA interference STAT3 Apoptosis Differentiation Proliferation 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Prados MD, Levin V (2000) Biology and treatment of malignant glioma. Semin Oncol 27(3):1–10PubMedGoogle Scholar
  2. 2.
    Wechsler-Reya R, Scott MP (2001) The developmental biology of brain tumors. Annu Rev Neurosci 24:385–428. doi: 10.1146/annurev.neuro.24.1.385 PubMedCrossRefGoogle Scholar
  3. 3.
    Holland EC (2000) Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 97(12):6242–6244. doi: 10.1073/pnas.97.12.6242 PubMedCrossRefGoogle Scholar
  4. 4.
    Maher EA, Furnari FB, Bachoo RM et al (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15(11):1311–1333. doi: 10.1101/gad.891601 PubMedCrossRefGoogle Scholar
  5. 5.
    Nicholas MK (2007) Glioblastoma multiforme: evidence-based approach to therapy. Expert Rev Anticancer Ther 7(12):S23–S27. doi: 10.1586/14737140.7.12s.S23 PubMedCrossRefGoogle Scholar
  6. 6.
    Rahaman SO, Vogelbaum MA, Haque SJ (2005) Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Rα2. Cancer Res 65(7):2956–2963. doi: 10.1158/0008-5472.CAN-04-3592 PubMedCrossRefGoogle Scholar
  7. 7.
    Cattaneo E, Conti L, DeFraja C (1999) Signaling through the JAK-STAT pathway in the developing brain. Trends Neurosci 22(8):365–369. doi: 10.1016/S0166-2236(98)01378-2 PubMedCrossRefGoogle Scholar
  8. 8.
    Levy DE, Lee CK (2002) What does Stat3 do? J Clin Invest 109(9):1143–1148PubMedGoogle Scholar
  9. 9.
    Alvarez JV, Frank DA (2004) Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis. Cancer Biol Ther 3(11):1045–1050PubMedCrossRefGoogle Scholar
  10. 10.
    Blaskovich MA, Sun J, Cantor A et al (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63(6):1270–1279PubMedGoogle Scholar
  11. 11.
    Gao LF, Wen LJ, Yu H et al (2006) Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacol Sin 27(3):347–352. doi: 10.1111/j.1745-7254.2006.00277.x PubMedCrossRefGoogle Scholar
  12. 12.
    Zufferey R, Nagy D, Mandel RJ et al (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15(9):871–875. doi: 10.1038/nbt0997-871 PubMedCrossRefGoogle Scholar
  13. 13.
    Lee SO, Lou W, Qureshi KM et al (2004) RNA interference targeting stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate 60(4):303–309. doi: 10.1002/pros.20072 PubMedCrossRefGoogle Scholar
  14. 14.
    Konnikova L, Kotecki M, Kruger MM et al (2003) Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3:23–32. doi: 10.1186/1471-2407-3-23 PubMedCrossRefGoogle Scholar
  15. 15.
    Rosen DG, Mercado-Uribe I, Yang G et al (2006) The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107(11):2730–2740. doi: 10.1002/cncr.22293 PubMedCrossRefGoogle Scholar
  16. 16.
    Bonni A, Sun Y, Nadal-Vicens M et al (1997) Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278(5337):477–483. doi: 10.1126/science.278.5337.477 PubMedCrossRefGoogle Scholar
  17. 17.
    Turnley AM, Bartlett PF (2000) Cytokines that signal through the leukemia inhibitory factor receptor-β complex in the nervous system. J Neurochem 74(3):889–899. doi: 10.1046/j.1471-4159.2000.0740889.x PubMedCrossRefGoogle Scholar
  18. 18.
    Yanagisawa M, Nakashima K, Taga T (1999) STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M. Neurosci Lett 269(3):169–172. doi: 10.1016/S0304-3940(99)00447-4 PubMedCrossRefGoogle Scholar
  19. 19.
    Turkson J, Bowman T, Garcia R et al (1998) Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18(5):2545–2552PubMedGoogle Scholar
  20. 20.
    Bromberg JF, Horvath CM, Besser D et al (1998) Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18(5):2553–2558PubMedGoogle Scholar
  21. 21.
    Yu H, Jove R (2004) The STATs of cancer—new molecular targets come of age. Nat Rev Cancer 4(2):97–105. doi: 10.1038/nrc1275 PubMedCrossRefGoogle Scholar
  22. 22.
    Catlett-Falcone R, Landowski TH, Oshiro MM et al (1999) Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10(1):105–115. doi: 10.1016/S1074-7613(00)80011-4 PubMedCrossRefGoogle Scholar
  23. 23.
    Lewis DL, Hagstrom JE, Loomis AG et al (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 32(1):107–108. doi: 10.1038/ng944 PubMedCrossRefGoogle Scholar
  24. 24.
    Bowman T, Garcia R, Turkson J et al (2000) STATs in oncogenesis. Oncogene 19(21):2474–2488. doi: 10.1038/sj.onc.1203527 PubMedCrossRefGoogle Scholar
  25. 25.
    Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13(12):1501–1512. doi: 10.1101/gad.13.12.1501 PubMedCrossRefGoogle Scholar
  26. 26.
    Bromberg JF, Wrzeszczynska MH, Devgan G et al (1999) Stat3 as an oncogene. Cell 98(3):295–303. doi: 10.1016/S0092-8674(00)81959-5 PubMedCrossRefGoogle Scholar
  27. 27.
    Riffkin CD, Gray AZ, Hawkins CJ et al (2001) Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction. Neuro-oncology 3(4):229–240. doi: 10.1215/15228517-3-4-229 PubMedCrossRefGoogle Scholar
  28. 28.
    Rieger J, Ohgaki H, Kleihues P et al (1999) Human astrocytic brain tumors express AP02L/TRAIL. Acta Neuropathol 97(1):1–4. doi: 10.1007/s004010050948 PubMedCrossRefGoogle Scholar
  29. 29.
    Grandis JR, Drenning SD, Zeng Q et al (2000) Constitutive activation of that stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA 97(8):4227–4232. doi: 10.1073/pnas.97.8.4227 PubMedCrossRefGoogle Scholar
  30. 30.
    Scott S, Higdon R, Beckett L et al (2002) Bcl2 antisense reduces prostate cancer cell survival following irradiation. Cancer Biother Radiopharm 17(6):647–656. doi: 10.1089/108497802320970253 PubMedCrossRefGoogle Scholar
  31. 31.
    Yang BC, Wang YS, Wang CH et al (1999) Transient apoptosis elicited by insulin in serum-starved glioma cells involves Fas/Fas-L and Bcl-2. Cell Biol Int 23(8):533–540. doi: 10.1006/cbir.1999.0408 PubMedCrossRefGoogle Scholar
  32. 32.
    de la Iglesia N, Konopka G, Puram SV et al (2008) Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 22(4):449–462. doi: 10.1101/gad.1606508 PubMedCrossRefGoogle Scholar
  33. 33.
    de la Iglesia N, Konopka G, Lim KL et al (2008) Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 28(23):5870–5878. doi: 10.1523/JNEUROSCI.5385-07.2008 PubMedCrossRefGoogle Scholar
  34. 34.
    Nakashima K, Yanagisawa M, Arakawa H et al (1999) Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284(5413):479–482. doi: 10.1126/science.284.5413.479 PubMedCrossRefGoogle Scholar
  35. 35.
    Rajan P, McKay RD (1998) Multiple routes to astrocytic differentiation in the CNS. J Neurosci 18(10):3620–3629PubMedGoogle Scholar
  36. 36.
    Gu F, Hata R, Ma YJ et al (2005) Suppression of stat3 promotes neurogenesis in cultured neural stem cells. J Neurosci Res 81(2):163–171. doi: 10.1002/jnr.20561 PubMedCrossRefGoogle Scholar
  37. 37.
    Cao F, Hata R, Zhu P et al (2006) Overexpression of SOCS3 inhibits astrogliogenesis and promotes maintenance of neural stem cells. J Neurochem 98(2):459–470. doi: 10.1111/j.1471-4159.2006.03890.x PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Guang-hui Li
    • 1
  • Hong Wei
    • 2
  • Zheng-tang Chen
    • 1
  • Sheng-qing Lv
    • 3
  • Chang-lin Yin
    • 4
  • Dong-lin Wang
    • 1
    • 5
  1. 1.Institute for Cancer Research in People’s Liberation Army, Xinqiao HospitalThird Military Medical UniversityChongqingChina
  2. 2.Department of Plastic Surgery, Southwest HospitalThird Military Medical UniversityChongqingChina
  3. 3.Department of Neurosurgery, Xinqiao HospitalThird Military Medical UniversityChongqingChina
  4. 4.Department of Emergency, Southwest HospitalThird Military Medical UniversityChongqingChina
  5. 5.Department of Oncology, Tongji HospitalTongji UniversityShanghaiChina

Personalised recommendations